Further, overexpression of PLK1 played a critical role in tumors that have escaped estrogen deprivation therapy[46,47], and was a strong predictor of worse survival in a large cohort of ER-positive BC patients[46-48]. This evidence concerns the gene ESR1 and breast cancer.